Wolfgang Schütte

Erlotinib treatment after platinum-based therapy in elderly patients with non-small-cell lung cancer in routine clinical practice - results from the ElderTac study.

Authors:

Wolfgang M Brueckl H Jost Achenbach Joachim H Ficker Wolfgang Schuette

BMC Cancer 2018 03 27;18(1):333. Epub 2018 Mar 27.

Hospital Martha-Maria Halle-Doelau, Klinik für Innere Medizin II, Röntgenstr. 1, Halle, Germany.

View Article and Find Full Text PDF

March 2018

Treatment decisions, clinical outcomes, and pharmacoeconomics in the treatment of patients with EGFR mutated stage III/IV NSCLC in Germany: an observational study.

Authors:

Wolfgang Schuette Peter Schirmacher Wilfried E E Eberhardt Manfred Dietel Ute Zirrgiebel Lars Muehlenhoff Michael Thomas

BMC Cancer 2018 Feb 5;18(1):135. Epub 2018 Feb 5.

Internistische Onkologie der Thoraxtumoren, Thoraxklinik im Universitätsklinikum Heidelberg, Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research, Heidelberg, Germany.

View Article and Find Full Text PDF

February 2018

65Plus: open-label study of bevacizumab in combination with pemetrexed or pemetrexed/carboplatin as first-line treatment of patients with advanced or recurrent nonsquamous non-small-cell lung cancer.

Authors:

Wolfgang Schuette Claus-Peter Schneider Walburga Engel-Riedel Christian Schumann Martin Kohlhaeufl Monika Heidi Ursel Serke Gert Hoeffken Cornelius Kortsik Martin Reck

Lung Cancer (Auckl) 2017 6;8:217-229. Epub 2017 Nov 6.

Department of Thoracic Oncology, Lung Clinic, Grosshansdorf, Germany.

View Article and Find Full Text PDF

November 2017

Meta-analysis of pemetrexed plus carboplatin doublet safety profile in first-line non-squamous non-small cell lung cancer studies.

Authors:

Isamu Okamoto Wolfgang H W Schuette Thomas E Stinchcombe José Rodrigues-Pereira Belén San Antonio Jian Chen Jingyi Liu William J John Ralph G Zinner

Curr Med Res Opin 2017 May 12;33(5):937-941. Epub 2017 Mar 12.

g Thomas Jefferson University , Philadelphia , PA , USA.

View Article and Find Full Text PDF

May 2017

A randomized Phase 2 study of pemetrexed in combination with cisplatin or carboplatin as adjuvant chemotherapy in patients with completely resected stage IB or II Non-Small-Cell Lung Cancer.

Authors:

Gerald Schmid-Bindert Walburga Engel-Riedel Martin Reck Wolfgang Schuette Jan Stöhlmacher Jürgen R Fischer Julien Mazières Christos Chouaid Martin Wolf Nuria Vinolas Victoria Soldatenkova Veronique Ripoche Tuan Nguyen Carla Visseren-Grul

Lung Cancer 2015 Dec 7;90(3):397-404. Epub 2015 Nov 7.

Lilly Oncology Europe, Grootslag 1-5, Houten, the Netherlands. Electronic address:

View Article and Find Full Text PDF

December 2015

CHAMP: A Phase II Study of Panitumumab With Pemetrexed and Cisplatin Versus Pemetrexed and Cisplatin in the Treatment of Patients With Advanced-Stage Primary Nonsquamous Non-Small-Cell Lung Cancer With Particular Regard to the KRAS Status.

Authors:

Wolfgang Schuette Dirk Behringer Jan Stoehlmacher Jens Kollmeier Sibylle Schmager Ludwig Fischer von Weikersthal Christian Schumann Joerg Buchmann

Clin Lung Cancer 2015 Nov 2;16(6):447-56. Epub 2015 Jun 2.

Hospital Martha-Maria Halle-Doelau, Institute of Pathology, Halle, Germany.

View Article and Find Full Text PDF

November 2015

EGFR mutation status and first-line treatment in patients with stage III/IV non-small cell lung cancer in Germany: an observational study.

Authors:

Wolfgang Schuette Peter Schirmacher Wilfried Ernst Erich Eberhardt Juergen R Fischer J-Matthias Graf von der Schulenburg Joerg Mezger Christian Schumann Monika Serke Silke Zaun Manfred Dietel Michael Thomas

Cancer Epidemiol Biomarkers Prev 2015 Aug 12;24(8):1254-61. Epub 2015 Jun 12.

Department of Thoracic Oncology, Thoraxklinik at the University of Heidelberg, Heidelberg, Germany. Translational Lung Research Center Heidelberg (TLRC-H), Member of the German Center for Lung Research (DZL), Heidelberg, Germany.

View Article and Find Full Text PDF

August 2015